A detailed history of Madison Avenue Partners, LP transactions in Galapagos Nv stock. As of the latest transaction made, Madison Avenue Partners, LP holds 1,877,011 shares of GLPG stock, worth $59.4 Million. This represents 5.63% of its overall portfolio holdings.

Number of Shares
1,877,011
Holding current value
$59.4 Million
% of portfolio
5.63%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$23.04 - $29.2 $43.2 Million - $54.8 Million
1,877,011 New
1,877,011 $52.5 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $2.09B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Madison Avenue Partners, LP Portfolio

Follow Madison Avenue Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Madison Avenue Partners, LP with notifications on news.